Studium Genetics at Medlab Middle East 2024, Dubai

Studium Genetics, the spin-off Company of Alma Mater Studiorum – University of Bologna, is going to exhibit at Medlab Middle East – Dubai World Trade Center from 5th to 8th February 2024. We are excited to invite you to visit us at booth D53 – Hall Z1 – Italia Pavillon to discover the unique and patented Studium Genetics Collection Kit SG-OCRA™ to access the oral carcinoma risk both in diagnostic and prognostic activities. Prof. Luca Morandi, co-founder and inventor, will be pleased to introduce the Technology. To set a time for a meeting please get in touch writing an e-mail to…

San Raffaele Hospital in Milan bets on early detection of oral cancer

Introduced a new salivary test developed by Studium Genetics, a spin-off of Alma Mater Studiorum - University of Bologna. Milan, Nov. 8, 2023 - A simple salivary test could revolutionize the diagnosis of oral cancers, detecting them in the early stages with outstanding precision. The discovery is the result of research conducted by Studium Genetics, a spin-off of the Alma Mater Studiorum – University of Bologna, which has chosen IRCCS San Raffaele Hospital in Milan (San Donato Group) as a partner to introduce the new methodology into clinical practice and research. The new epigenetic test is based on quantitative analysis…